Back
Corporate News
Jagsonpal Pharmaceuticals to review quarterly results at a board meeting on October 28
21-Oct-2026, 06:03
Jagsonpal Pharmaceuticals Limited will hold a board meeting on Wednesday, October 28, 2026, to consider and approve the unaudited financial results (standalone and consolidated) for the quarter ended September 30, 2026, the company said in a filing with the BSE Ltd and National Stock Exchange of India Ltd. The trading window for the company's securities will remain closed until October 30, 2026, according to a prior communication dated September 25, 2026.